These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33031926)

  • 1. Cancer stem cell antigens as targets for new combined anti-cancer therapies.
    Quaglino E; Cavallo F; Conti L
    Int J Biochem Cell Biol; 2020 Dec; 129():105861. PubMed ID: 33031926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer stem cell antigens as targets for immunotherapy.
    Quaglino E; Conti L; Cavallo F
    Semin Immunol; 2020 Feb; 47():101386. PubMed ID: 31932198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Identification of cancer-stem cell antigens and development of CTL-mediated cancer immunotherapy].
    Miyamoto S; Kanaseki T; Hirohashi Y; Tsukahara T; Kikuchi Y; Sato N; Torigoe T
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):40-47. PubMed ID: 28539553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A New Approach for Cancer Immunotherapy Based on the Cancer Stem Cell Antigens Properties.
    Mahmoodi S; Nezafat N; Negahdaripour M; Ghasemi Y
    Curr Mol Med; 2019; 19(1):2-11. PubMed ID: 30714514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal cancer stem cells as targets for innovative immunotherapy.
    Chivu-Economescu M; Necula LG; Matei L; Dragu DL; Neagu AI; Alexiu I; Bleotu C; Diaconu CC
    World J Gastroenterol; 2020 Apr; 26(14):1580-1593. PubMed ID: 32327907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concise Review: Targeting Cancer Stem Cells Using Immunologic Approaches.
    Pan Q; Li Q; Liu S; Ning N; Zhang X; Xu Y; Chang AE; Wicha MS
    Stem Cells; 2015 Jul; 33(7):2085-92. PubMed ID: 25873269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concise Review: Targeting Cancer Stem Cells and Their Supporting Niche Using Oncolytic Viruses.
    Crupi MJF; Bell JC; Singaravelu R
    Stem Cells; 2019 Jun; 37(6):716-723. PubMed ID: 30875126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer stem cells: Regulation programs, immunological properties and immunotherapy.
    Zhang D; Tang DG; Rycaj K
    Semin Cancer Biol; 2018 Oct; 52(Pt 2):94-106. PubMed ID: 29752993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic Targeting of Cancer Stem Cells.
    Zhang J; Li Q; Chang AE
    Surg Oncol Clin N Am; 2019 Jul; 28(3):431-445. PubMed ID: 31079798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges and opportunities for cancer stem cell-targeted immunotherapies include immune checkpoint inhibitor, cancer stem cell-dendritic cell vaccine, chimeric antigen receptor immune cells, and modified exosomes.
    Alqarni A; Jasim SA; Altalbawy FMA; Kaur H; Kaur I; Rodriguez-Benites C; Deorari M; Alwaily ER; Al-Ani AM; Redhee AH
    J Biochem Mol Toxicol; 2024 Jun; 38(6):e23719. PubMed ID: 38764138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell immunology and immunotherapy: Harnessing the immune system against cancer's source.
    Ruiu R; Tarone L; Rolih V; Barutello G; Bolli E; Riccardo F; Cavallo F; Conti L
    Prog Mol Biol Transl Sci; 2019; 164():119-188. PubMed ID: 31383404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrin β4-Targeted Cancer Immunotherapies Inhibit Tumor Growth and Decrease Metastasis.
    Ruan S; Lin M; Zhu Y; Lum L; Thakur A; Jin R; Shao W; Zhang Y; Hu Y; Huang S; Hurt EM; Chang AE; Wicha MS; Li Q
    Cancer Res; 2020 Feb; 80(4):771-783. PubMed ID: 31843981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy for targeting cancer stem cells in hepatocellular carcinoma.
    Dai X; Guo Y; Hu Y; Bao X; Zhu X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Fang W
    Theranostics; 2021; 11(7):3489-3501. PubMed ID: 33537099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Cancer Stem Cell Targeted Therapy.
    Akbulut H; Babahan C; Abgarmi SA; Ocal M; Besler M
    Crit Rev Oncog; 2019; 24(1):1-20. PubMed ID: 31679215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunotherapy: A Potential Approach to Targeting Cancer Stem Cells.
    Wang W; Bai L; Xu D; Li W; Cui J
    Curr Cancer Drug Targets; 2021; 21(2):117-131. PubMed ID: 32364076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Cancer Stem Cells with Natural Killer Cell Immunotherapy.
    Luna JI; Grossenbacher SK; Murphy WJ; Canter RJ
    Expert Opin Biol Ther; 2017 Mar; 17(3):313-324. PubMed ID: 27960589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response against tumor antigens expressed on human cancer stem-like cells/tumor-initiating cells.
    Hirohashi Y; Torigoe T; Inoda S; Takahashi A; Morita R; Nishizawa S; Tamura Y; Suzuki H; Toyota M; Sato N
    Immunotherapy; 2010 Mar; 2(2):201-11. PubMed ID: 20635928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining vaccines and immune checkpoint inhibitors to prime, expand, and facilitate effective tumor immunotherapy.
    Collins JM; Redman JM; Gulley JL
    Expert Rev Vaccines; 2018 Aug; 17(8):697-705. PubMed ID: 30058393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficiency of G2/M-related tumor-associated antigen-targeting cancer immunotherapy depends on antigen expression in the cancer stem-like population.
    Mori T; Nishizawa S; Hirohashi Y; Torigoe T; Tamura Y; Takahashi A; Kochin V; Fujii R; Kondo T; Greene MI; Hara I; Sato N
    Exp Mol Pathol; 2012 Feb; 92(1):27-32. PubMed ID: 22001602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotargeting of the xCT Cystine/Glutamate Antiporter Potentiates the Efficacy of HER2-Targeted Immunotherapies in Breast Cancer.
    Conti L; Bolli E; Di Lorenzo A; Franceschi V; Macchi F; Riccardo F; Ruiu R; Russo L; Quaglino E; Donofrio G; Cavallo F
    Cancer Immunol Res; 2020 Aug; 8(8):1039-1053. PubMed ID: 32532810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.